Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BNC
CEA Industries
$2.74
+3.4%
$2.63
$1.84
$27.39
$112.81M0.56325,064 shs250,466 shs
Hillstream Biopharma Inc. stock logo
CNTN
Hillstream Biopharma
$2.15
+2.9%
$2.42
$1.75
$9.08
$171.31M1.45840,858 shs496,009 shs
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
$3.18
+4.6%
$2.91
$2.34
$15.00
$49.42M2.53445,228 shs902,301 shs
TONX
Verb Technology
$2.78
$3.08
$1.75
$21.78
$153.10M0.68429,511 shs41,646 shs
7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BNC
CEA Industries
+5.16%+5.16%-9.56%+1.15%+264,999,900.00%
Hillstream Biopharma Inc. stock logo
CNTN
Hillstream Biopharma
+3.98%+6.09%+1.95%-37.61%+208,999,900.00%
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
+12.59%+13.01%+11.76%-22.05%-53.80%
TONX
Verb Technology
+6.11%-3.14%-19.42%-25.07%+277,999,900.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BNC
CEA Industries
$2.74
+3.4%
$2.63
$1.84
$27.39
$112.81M0.56325,064 shs250,466 shs
Hillstream Biopharma Inc. stock logo
CNTN
Hillstream Biopharma
$2.15
+2.9%
$2.42
$1.75
$9.08
$171.31M1.45840,858 shs496,009 shs
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
$3.18
+4.6%
$2.91
$2.34
$15.00
$49.42M2.53445,228 shs902,301 shs
TONX
Verb Technology
$2.78
$3.08
$1.75
$21.78
$153.10M0.68429,511 shs41,646 shs
7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BNC
CEA Industries
+5.16%+5.16%-9.56%+1.15%+264,999,900.00%
Hillstream Biopharma Inc. stock logo
CNTN
Hillstream Biopharma
+3.98%+6.09%+1.95%-37.61%+208,999,900.00%
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
+12.59%+13.01%+11.76%-22.05%-53.80%
TONX
Verb Technology
+6.11%-3.14%-19.42%-25.07%+277,999,900.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
BNC
CEA Industries
1.00
SellN/AN/A
Hillstream Biopharma Inc. stock logo
CNTN
Hillstream Biopharma
1.00
SellN/AN/A
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
2.00
Hold$7.20126.42% Upside
TONX
Verb Technology
1.00
SellN/AN/A

Current Analyst Ratings Breakdown

Latest HYPD, CNTN, TONX, and BNC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/18/2026
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
UpgradeSell (D-)Sell (D)
8/13/2026
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
Boost Price TargetOverweight$6.60 ➝ $7.10
8/12/2026
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
DowngradeHoldStrong Sell
8/11/2026
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
Reiterated RatingBuy$7.30
7/28/2026
BNC
CEA Industries
UpgradeSell (D)Sell (D+)
7/15/2026
Hillstream Biopharma Inc. stock logo
CNTN
Hillstream Biopharma
DowngradeSell (D-)Sell (E+)
7/14/2026
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
UpgradeStrong SellHold
7/6/2026
BNC
CEA Industries
Reiterated RatingSell (D)
7/6/2026
TONX
Verb Technology
UpgradeSell (E+)Sell (D-)
7/1/2026
Hillstream Biopharma Inc. stock logo
CNTN
Hillstream Biopharma
UpgradeSell (E+)Sell (D-)
7/1/2026
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
Boost Price TargetOverweight$4.00 ➝ $6.60
(Data available from 8/20/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
BNC
CEA Industries
$29.33M3.85$2.95 per share0.93$7.11 per share0.39
Hillstream Biopharma Inc. stock logo
CNTN
Hillstream Biopharma
N/AN/AN/AN/A$5.71 per shareN/A
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
$810K61.01N/AN/A$6.56 per share0.48
TONX
Verb Technology
$12.78M11.98N/AN/A$7.24 per share0.38
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
BNC
CEA Industries
$115.26M$5.650.48N/AN/A392.91%81.62%67.22%N/A
Hillstream Biopharma Inc. stock logo
CNTN
Hillstream Biopharma
-$35.92M-$0.50N/AN/AN/AN/A-20.06%-15.90%N/A
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
-$45.31M-$6.53N/A2.97N/A416.56%-11.62%-9.96%N/A
TONX
Verb Technology
-$148.48M-$2.84N/AN/AN/A-497.15%-60.82%-59.56%N/A

Latest HYPD, CNTN, TONX, and BNC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/13/2026Q2 2026
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
N/A$0.92N/A$0.92N/A$0.36 million
6/23/2026Q4 2026
BNC
CEA Industries
N/A$6.20N/A$6.20N/A$7.35 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
BNC
CEA Industries
N/AN/AN/AN/AN/A
Hillstream Biopharma Inc. stock logo
CNTN
Hillstream Biopharma
N/AN/AN/AN/AN/A
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
N/AN/AN/AN/AN/A
TONX
Verb Technology
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
BNC
CEA Industries
N/A
1.18
0.72
Hillstream Biopharma Inc. stock logo
CNTN
Hillstream Biopharma
N/A
15.70
37.76
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
0.06
2.34
1.97
TONX
Verb Technology
N/A
6.39
6.39

Institutional Ownership

CompanyInstitutional Ownership
BNC
CEA Industries
N/A
Hillstream Biopharma Inc. stock logo
CNTN
Hillstream Biopharma
1.16%
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
25.84%
TONX
Verb Technology
7.24%

Insider Ownership

CompanyInsider Ownership
BNC
CEA Industries
2.70%
Hillstream Biopharma Inc. stock logo
CNTN
Hillstream Biopharma
3.34%
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
7.50%
TONX
Verb Technology
21.43%
CompanyEmployeesShares OutstandingFree FloatOptionable
BNC
CEA Industries
3041.17 million40.06 millionN/A
Hillstream Biopharma Inc. stock logo
CNTN
Hillstream Biopharma
279.68 million74.55 millionN/A
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
4015.54 million14.37 millionNo Data
TONX
Verb Technology
17055.07 million43.27 millionN/A

Recent News About These Companies

Verb Technology (NASDAQ:TONX) Upgraded to Hold at Wall Street Zen
TON Strategy Company Advances Share Repurchase Program

New MarketBeat Followers Over Time

Media Sentiment Over Time

CEA Industries NASDAQ:BNC

$2.74 +0.09 (+3.40%)
As of 01:58 PM Eastern

CEA Industries Inc. provides technology, engineering, and other services to the controlled environment agriculture (CEA) industry worldwide. It offers floor plans and architectural design for cultivation facilities; licensed mechanical, electrical, and plumbing engineering services for commercial scale environmental control systems that are specific to cultivation facilities; and process cooling systems and other climate control systems. The company also provides air handling equipment and systems; LED lighting; benching and racking solutions for indoor cultivation; automation and control devices, systems, and technologies for environmental, lighting, and climate control applications; and preventive maintenance services for CEA facilities. It serves commercial, as well as state- and provincial-regulated CEA growers. The company was formerly known as Surna Inc. and changed its name to CEA Industries Inc. in November 2021. CEA Industries Inc. was founded in 2006 and is headquartered in Louisville, Colorado.

Hillstream Biopharma stock logo

Hillstream Biopharma NASDAQ:CNTN

$2.15 +0.06 (+2.87%)
As of 02:04 PM Eastern

Hillstream BioPharma, Inc., a pre-clinical biotechnology company, develops novel therapeutic candidates targeting ferroptosis, an anti-cancer mechanism resulting in iron mediated cell death (IMCD) for the treatment resistant cancers. The company's product candidate is HSB-1216, an IMCD inducer targeting solid tumors. It also develops HSB-888, a dual Quatramer loaded IMCD inducer coupled with its anthracycline analogue for solid tumors; HSB-510, a targeted bifunctional inhibitory compound in Quatramer with single digit nanomolar; IC50 against PI3K-delta and HDAC6, which is also known to downregulate; c-myc, a cancer drug target; and HSB-114, an immunotherapeutic agent, which uses its Quatramer technology to deliver tumor necrosis factor-alpha gene into cancer cells. The company was incorporated in 2019 and is based in Bridgewater, New Jersey.

Hyperion DeFi stock logo

Hyperion DeFi NASDAQ:HYPD

$3.18 +0.14 (+4.61%)
As of 02:03 PM Eastern

Eyenovia, Inc., an ophthalmic technology company, engages in the development of therapeutics based on its proprietary microdose array print platform technology. The company's product candidates include MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; and Mydcombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis. It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; a license agreement with Arctic Vision (Hong Kong) Limited to develop and commercialize MicroPine, MicroLine, and Mydcombi in China and South Korea; and Senju Pharmaceutical Co., Ltd. to develop and commercialize MicroPine, MicroLine, and Mydcombi. The company was formerly known as PGP Holdings V, Inc. and changed its name to Eyenovia, Inc. in May 2014. Eyenovia, Inc. was incorporated in 2014 and is based in New York, New York.

Verb Technology NASDAQ:TONX

$2.78 0.00 (0.00%)
As of 02:01 PM Eastern

Verb Technology Company, Inc. develops Software-as-a-Service applications platform in the United States, Japan, and internationally. It offers verbCRM, a customer relationship management (CRM) application; verbTEAMS, a CRM application for small and medium-sized businesses and solopreneurs; verbLEARN, a learning management system application that incorporates clickable in-video technology featured in its verbCRM application; and verbLIVE, a live eCommerce application. The company also provides non-digital services to enterprise clients, such as design and printing services for welcome and starter kits; fulfilment services, which include managing the preparation, handling, and shipping of custom-branded merchandise; and subscription-based application services. It serves large enterprises in the life sciences sector, professional sports franchises, educational institutions, and not-for-profit organizations, as well as clients in the entertainment industry and the burgeoning CBD industry, among other business sectors. The company was formerly known as nFüsz, Inc. and changed its name to Verb Technology Company, Inc. in February 2019. Verb Technology Company, Inc. was founded in 2012 and is based in American Fork, Utah.